Login
DaVita NYSE: DVA
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG).
| Name | DaVita |
| Ticker | DVA |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Kidney Failure |
| Price | 110.02 |
| 52W Low/High | 64.99 / 113.39 |
| Market cap | 13 B |
| 1Y Total Return |
51.79%
Strong |
| 1Y Volatility |
40.83%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
DaVita Inc., formerly DaVita HealthCare Partners Inc., operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG).
Details
| Ticker | DVA |
| Name | DaVita |
| ISIN | US23918K1088 |
| CUSIP | 23918K108 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Kidney Failure |
| Country | USA |
| Currency | U.S. Dollar |
| In Index(ices) | US S&P 500 Index |
Share as of 11/23/20
| Close Price | 110.02 |
| 52W Low/High | 64.99 / 113.39 |
| Market cap | 13 B |
| 1Y Total Return |
51.79%
Strong |
| 1Y Volatility |
40.83%
Low Risk |
| Beta | 1.56 |
| PE (trailing) |
16.77
Below Average |
| 12M Dividends | - |
| Last Dividend Date | - |
| Dividend Yield | - |
Fin. Strength
| Net Profit Margin | 7.3% |
| Cash from Op. / Cur. Liabilities | 0.87 |
| Diluted Earnings / Share | 6.56 |
| ROE | 43.4% |
| ROIC | 5.6% |
| Price / Revenue | 1.2 |
| Price / Book | 8.7 |
| Price / CF | 6.3 |
| Current Ratio | 1.4 |
| Cur.Liabilities / Tot.Liabilities | 0.2 |
| Financial Leverage | 7.05 |
| in Mils USD |
rolling-year up to September
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
11,544
|
11,311
|
11,365
|
7,774
|
10,763
|
13,576
|
|
| Gross Profit |
3,612
|
3,370
|
3,255
|
2,595
|
3,266
|
3,900
|
|
| R&D |
0
|
0
|
0
|
0
|
0
|
0
|
|
| EBITDA |
2,130
|
1,758
|
1,757
|
2,266
|
2,214
|
1,803
|
|
| Operating Income |
1,746
|
1,568
|
1,285
|
2,173
|
1,716
|
1,363
|
|
| Net Income exc. Extra |
845
|
416
|
613
|
518
|
716
|
484
|
|
| per Share | |||||||
| Diluted avg Shares |
124
|
151
|
167
|
191
|
207
|
217
|
|
| EPS exc. Extra |
6.56
|
2.64
|
3.30
|
2.63
|
3.47
|
2.21
|
|
| Dividend |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Div. Yield (an.) |
-
|
-
|
-
|
-
|
-
|
-
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
17,047
|
17,452
|
19,358
|
19,013
|
18,926
|
18,895
|
|
| Cash, Eq & Invt ShortTerm |
837
|
1,458
|
545
|
983
|
1,573
|
1,970
|
|
| Total Current Assets |
3,430
|
3,999
|
8,930
|
4,034
|
4,261
|
4,738
|
|
| Total Non-Current Assets |
13,617
|
13,453
|
10,428
|
14,980
|
14,664
|
14,157
|
|
| Intangibles |
6,986
|
6,883
|
6,800
|
10,867
|
10,959
|
11,314
|
|
| Total Liabilities |
13,989
|
13,643
|
14,264
|
13,017
|
12,835
|
12,805
|
|
| Total Current Liabilities |
2,499
|
2,207
|
4,855
|
2,875
|
2,639
|
2,411
|
|
| Long Term Debt |
11,490
|
11,437
|
9,409
|
10,143
|
10,195
|
10,395
|
|
| Shareholder equity |
1,575
|
2,319
|
3,825
|
4,785
|
4,912
|
4,990
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
2,175
|
1,781
|
1,727
|
2,059
|
1,918
|
1,051
|
|
| Depreciation |
627
|
612
|
620
|
782
|
695
|
628
|
|
| Cash from Investing |
-626
|
2,790
|
-921
|
-1,050
|
-989
|
-1,597
|
|
| Capex |
669
|
829
|
971
|
894
|
821
|
660
|
|
| Cash from Financing |
-2,074
|
-4,206
|
-660
|
-1,074
|
-1,061
|
68
|
|
| Stock Issued |
-1,565
|
-1,825
|
-1,629
|
-778
|
-762
|
-359
|
|
| Debt (LT) Issued |
-131
|
-2,116
|
1,109
|
-134
|
-195
|
600
|
|
| Free Cash Flow |
1,663
|
-3,212
|
3,667
|
1,131
|
1,039
|
14
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
7.3%
|
3.7%
|
5.4%
|
6.7%
|
6.7%
|
3.6%
|
|
| NCFO / Op.Income |
124.5%
|
113.6%
|
134.4%
|
94.8%
|
111.8%
|
77.1%
|
|
| Current Ratio |
1.4
|
1.8
|
1.8
|
1.4
|
1.6
|
2.0
|
|
| Financial Leverage D/E |
7.05
|
4.83
|
2.67
|
1.90
|
1.86
|
1.84
|
|
| Return on Capital Avg |
5.6%
|
5.2%
|
7.4%
|
5.0%
|
4.9%
|
6.1%
|
|
| Return on Shareholder Equity |
43.4%
|
13.6%
|
14.2%
|
10.7%
|
14.5%
|
9.7%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available